Inovio Biomedical to Present at Roth Capital Partners Growth Stock Investor Conference
Posted on: Tue, 09 Mar 2010 06:30:01 EST
SAN DIEGO, Mar 09, 2010 (BUSINESS WIRE) --
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, President and CEO, will present at Roth Capital Partners' 22nd Annual OC Growth Stock Conference on Monday, March 15th at 9:00 a.m. PT (12:00 noon ET). The conference is being held March 15-17, 2010, in Dana Point, California.